HFE rs1800544: Understanding the C282Y Variant
The rs1800544 variant, widely known as C282Y, is a specific genetic change in the HFE gene. It is the primary genetic factor associated with hereditary hemochromatosis, a condition characterized by the body's inability to properly regulate iron absorption, leading to potential iron overload.
What each genotype means
Typical iron metabolism
This is the most common genotype and is considered the reference or wild-type sequence for the HFE gene. Individuals with this genotype do not carry the C282Y mutation associated with hereditary hemochromatosis. No specific genetic predisposition to iron overload is indicated by this result.
This is the most common genotype in all global populations.
HFE variant carrier
You carry one copy of the C282Y variant and one typical copy of the HFE gene. Carriers are generally not at risk for developing hereditary hemochromatosis, though they may occasionally show slightly higher iron levels than non-carriers. You should discuss any concerns regarding iron levels or family history with your healthcare provider.
Carried by approximately 9% to 10% of individuals of Northern European ancestry.
Increased iron overload risk
This genotype indicates you have two copies of the C282Y variant, which is the primary genetic cause of hereditary hemochromatosis. While this genotype is associated with high biochemical penetrance (elevated iron markers), the clinical penetrance is incomplete, meaning not all individuals will develop severe iron-related disease. Please consult with a physician to discuss appropriate monitoring of your iron levels and clinical follow-up.
Carried by approximately 1 in 200 to 1 in 250 people of Northern European descent.
What is the rs1800544 Variant?
The rs1800544 variant is a single nucleotide polymorphism (SNP) located within the HFE gene on the short arm of chromosome 6. In scientific literature, this variant is frequently referred to as C282Y, which describes the substitution of the amino acid cysteine with tyrosine at position 282 of the HFE protein. This specific change alters the structure of the protein, which is critical for the body's iron regulation processes. Because this variant is located in a gene that plays a central role in how cells sense and manage iron levels, researchers have studied it extensively to understand how it contributes to iron accumulation in various organs, such as the liver, heart, and pancreas. It is considered a medically actionable variant, meaning that identifying its presence can be relevant for clinical health monitoring.
The Role of the HFE Gene
The HFE gene provides instructions for producing the HFE protein, which is found on the surface of many cells. This protein interacts with other molecules to regulate the amount of iron absorbed from the diet. Under normal conditions, the HFE protein helps signal the body to stop absorbing excess iron when stores are sufficient. When the C282Y variant is present, the resulting protein may not function correctly, leading to a failure in this feedback loop. Consequently, the body continues to absorb iron from the digestive tract even when iron levels are already high. Over time, this excess iron is deposited in tissues and organs, which can lead to the clinical symptoms associated with hereditary hemochromatosis. Understanding this mechanism is essential for researchers studying iron-related disorders and for clinicians managing patients with iron overload.
Research and Clinical Associations
Research has established a strong association between the C282Y variant and hereditary hemochromatosis. Studies indicate that 80% to 90% of individuals diagnosed with this condition are homozygous for the C282Y allele. However, it is important to note that the clinical penetrance—the likelihood that an individual with the genotype will actually develop severe disease—is incomplete. Many people who carry two copies of the variant never develop significant clinical symptoms. Factors such as sex, age, and environmental influences play a role in whether iron overload becomes symptomatic. Because of this, the presence of the variant does not guarantee that an individual will experience health complications. Clinical guidelines emphasize that genetic testing results should be interpreted by a healthcare professional who can consider the patient's overall health, iron studies, and family history.
What You Can and Cannot Do
If you are aware of your status regarding the rs1800544 variant, it is important to understand the limitations of this information. Genetic testing for this variant can identify if you carry the alleles, but it cannot predict with certainty whether you will develop iron overload or how severe it might be. You cannot use this information to self-diagnose or initiate medical treatments, such as therapeutic phlebotomy, without professional guidance. If you have concerns about your iron levels or your genetic risk, the most appropriate step is to consult with a physician or a genetic counselor. They can order blood tests, such as serum ferritin and transferrin saturation, which are the standard tools for assessing iron status. Always discuss any health-related genetic findings with a qualified clinician who can provide context based on your personal medical history.
How common is this variant?
The C282Y variant is most common in populations of Northern European ancestry, with allele frequencies reaching up to 11.4% in some regions like Southern Ireland. It is significantly rarer in other global populations, such as those of East Asian or African descent.
Frequently asked questions
Does having the C282Y variant mean I have hemochromatosis?
No, having the variant does not mean you have the disease. Many people who are homozygous for C282Y never develop clinical iron overload, as the condition has incomplete penetrance.
What should I do if I know I have the C282Y variant?
You should discuss your results with a healthcare provider. They may recommend routine blood tests to monitor your iron levels, such as serum ferritin and transferrin saturation.
Is the C282Y variant the only cause of hemochromatosis?
While C282Y is the most common cause, other mutations in the HFE gene, such as H63D, or mutations in other genes can also lead to iron overload. Genetic testing can help clarify the specific cause.
Can I change my risk if I have the variant?
You cannot change your genetics, but you can manage your health. Regular medical monitoring and following your doctor's advice regarding diet and iron intake are the best ways to manage potential risks.
Sources & further reading
Educational information only, last refreshed 9/25/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1800544?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in HFE
The Ser65Cys missense polymorphism in HFE linked to mild systemic iron regulation changes and downstream impacts on hypogonadotropic reproductive function.
The C282Y missense variant in HFE is the primary genetic cause of hereditary hemochromatosis, leading to iron overload.
Common HFE missense variant H63D associated with hereditary hemochromatosis and mild iron overload risk.
HFE p.His63Asp (H63D) variant contributing to hereditary hemochromatosis risk, especially in compound heterozygosity with C282Y.
Coding variant (p.Val162Met) in the homeostatic iron regulator gene studied alongside classical hemochromatosis variants.
Known as HFE S65C (c.193A>T), this missense variant is associated with mild variations in transferrin saturation and iron accumulation, often evaluated alongside C282Y and H63D.